Taimed's Conference May 31 of 2021Dear All
Taimed just held a conference on May 31 and their CEO disclosed something which might interest you. I summarize them as follows :
1. There are around 400 patients using Trogarzo currently and
the figure might reach 1500 at peak. If my memory is correct
Spceo already predicted such long before.
2. No single one new patient increased in the year of 2021
because of pandemic.
3. Thera. sacked all the sales staff in 2021 and changed their
sales strategy from focusing on the bars ( hanging some
advertisement posts there) to reaching the KOL and
physicians directly.
4. Taimed is very disappointed with the present sales of Trogarzo.
5. Regarding IV push:
All patients will be enrolled in July and wish can apply to
FDA for label extension in September of 2021.
6. Regarding IM push: Will enroll all patients within 6 to nine
months and try to apply to FDA for label extension in the latte
r half of 2022. The cost of this project is around 3 millions US
dollars which will be covered by Thera.
And Taimeds just disclosed the sales volumes of May which is 5.2 millions NT dollars.
Thanks for your attention
Stock from Taiwan